Intermede Investment Partners

CEO and Portfolio Manager Barry Dargan holds full discretion over the portfolio. He founded the firm in 2010 and previously spent a decade at Capital Group managing international equity mandates. There is no investment committee override mechanism disclosed publicly.

The firm typically holds 25 to 35 positions across its global equity strategy. Concentrated portfolios are designed around high-conviction names where the investment team identifies durable competitive moats and long reinvestment runways. This level of concentration is materially higher than the benchmark-hugging norms of standard global equity funds.

Intermede operates exclusively as a long-only public equity manager. The firm does not market private-market or venture vehicles. However, its growth-stage mandate frequently intersects with late-stage venture-backed companies at or around their IPOs, giving the strategy a de facto crossover posture during initial public listing windows.

The strategy covers developed and emerging markets, with significant historical allocations in North America, Europe, and China. The geographic footprint is driven by bottom-up stock selection rather than top-down regional allocations. No country-weight constraints force capital into a geography without a supporting investment thesis.

The firm runs an internal fundamental research process led by Dargan and a compact analyst team drawn from firms including Fidelity, Goldman Sachs, and Morgan Stanley. Given the concentrated book, the research pipeline must produce a small number of deeply researched ideas each year. The firm does not publicly describe a formal external sourcing network.